AAAAAA
Results:
1-17
|
Results: 17
Authors:
Goh, BC
Ratain, MJ
Bertucci, D
Smith, R
Mani, S
Vogelzang, NJ
Schilsky, RL
Hutchison, M
Smith, M
Averbuch, S
Douglass, E
Citation: Bc. Goh et al., Phase I study of ZD9331 on short daily intravenous bolus infusion for 5 days every 3 weeks with fixed dosing recommendations, J CL ONCOL, 19(5), 2001, pp. 1476-1484
Authors:
Sargent, DJ
Niedzwiecki, D
O'Connell, MJ
Schilsky, RL
Citation: Dj. Sargent et al., Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer., N ENG J MED, 345(2), 2001, pp. 144-145
Authors:
Mani, S
Vogelzang, NJ
Bertucci, D
Stadler, WM
Schilsky, RL
Ratain, MJ
Citation: S. Mani et al., Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors - A potential broadly active regimen for advanced solid tumor malignancies, CANCER, 92(6), 2001, pp. 1567-1576
Authors:
Meropol, NJ
Niedzwiecki, D
Hollis, D
Schilsky, RL
Mayer, RJ
Citation: Nj. Meropol et al., Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma, CANCER, 91(7), 2001, pp. 1256-1263
Authors:
Kindler, HL
Schilsky, RL
Citation: Hl. Kindler et Rl. Schilsky, Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase, EXPERT OP I, 9(7), 2000, pp. 1635-1649
Authors:
Schilsky, RL
Dolan, ME
Bertucci, D
Ewesuedo, RB
Vogelzang, NJ
Mani, S
Wilson, LR
Ratain, MJ
Citation: Rl. Schilsky et al., Phase I clinical and pharmacological study of O-6-benzylguanine followed by carmustine in patients with advanced cancer, CLIN CANC R, 6(8), 2000, pp. 3025-3031
Authors:
Schilsky, RL
Bukowski, R
Burris, H
Hochster, H
O'Rourke, M
Wall, JG
Mani, S
Bonny, T
Levin, J
Hohneker, J
Citation: Rl. Schilsky et al., A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer, ANN ONCOL, 11(4), 2000, pp. 415-420
Authors:
Schilsky, RL
Citation: Rl. Schilsky, Pharmacology and clinical status of capecitabine, ONCOLOGY-NY, 14(9), 2000, pp. 1297-1306
Authors:
Ewesuedo, RB
Iyer, L
Das, S
Koenig, A
Mani, S
Vogelzang, NJ
Schilsky, RL
Brenckman, W
Ratain, MJ
Citation: Rb. Ewesuedo et al., Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer, J CL ONCOL, 19(7), 2000, pp. 2084-2090
Authors:
Mani, S
Hochster, H
Beck, T
Chevlen, EM
O'Rourke, MA
Weaver, CH
Bell, WN
White, R
McGuirt, C
Levin, J
Hohneker, J
Schilsky, RL
Lokich, J
Citation: S. Mani et al., Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer, J CL ONCOL, 18(15), 2000, pp. 2894-2901
Authors:
Williams, SF
Schilsky, RL
Citation: Sf. Williams et Rl. Schilsky, Antineoplastic drugs administered during pregnancy, SEMIN ONCOL, 27(6), 2000, pp. 618-622
Authors:
Lamont, EB
Schilsky, RL
Citation: Eb. Lamont et Rl. Schilsky, The oral fluoropyrimidines in cancer chemotherapy, CLIN CANC R, 5(9), 1999, pp. 2289-2296
Authors:
Costanza, ME
Weiss, RB
Henderson, IC
Norton, L
Berry, DA
Cirrincione, C
Winer, E
Wood, WC
Frei, E
McIntyre, OR
Schilsky, RL
Citation: Me. Costanza et al., Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: Report of a randomized study - Cancer and leukemia group B 8642, J CL ONCOL, 17(5), 1999, pp. 1397-1406
Authors:
Mani, S
Sciortino, D
Samuels, B
Arrietta, R
Schilsky, RL
Vokes, EE
Benner, S
Citation: S. Mani et al., Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma, INV NEW DR, 17(1), 1999, pp. 97-101
Authors:
Lamont, EB
Schilsky, RL
Citation: Eb. Lamont et Rl. Schilsky, Gonadal toxicity and teratogenicity after cytotoxic chemotherapy, ANTICANCER DRUG TOXICITY, 1999, pp. 491-523
Authors:
Mani, S
Schilsky, RL
Citation: S. Mani et Rl. Schilsky, New biochemical modulation strategies, PROG ANTI C, 2, 1999, pp. 54-83
Authors:
Mani, S
Kugler, JW
Knost, JA
Sciortino, DF
Gibbons, J
Garcia, JC
Ansari, RH
Schilsky, RL
Vokes, EE
Citation: S. Mani et al., Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer, INV NEW DR, 16(3), 1998, pp. 275-278
Risultati:
1-17
|